Brian H. Johnston

ORCID: 0000-0002-4948-5681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • Advanced biosensing and bioanalysis techniques
  • DNA and Nucleic Acid Chemistry
  • RNA and protein synthesis mechanisms
  • Synthetic Organic Chemistry Methods
  • RNA modifications and cancer
  • MicroRNA in disease regulation
  • CRISPR and Genetic Engineering
  • Viral Infections and Immunology Research
  • RNA Research and Splicing
  • Asymmetric Synthesis and Catalysis
  • Hepatitis C virus research
  • Bacteriophages and microbial interactions
  • Hepatitis B Virus Studies
  • Animal Genetics and Reproduction
  • Fluorine in Organic Chemistry
  • Biopolymer Synthesis and Applications
  • Molecular Biology Techniques and Applications
  • Wound Healing and Treatments
  • Aquaculture disease management and microbiota
  • Bacterial Genetics and Biotechnology
  • Origins and Evolution of Life
  • DNA Repair Mechanisms
  • Silk-based biomaterials and applications
  • Identification and Quantification in Food

SomaGenics (United States)
2008-2024

SRI International
1991-2018

Hunter College
2018

City University of New York
2018

University of Alberta
2018

Massachusetts Institute of Technology
1985-2018

Indiana University – Purdue University Indianapolis
2014

Stanford University
1996-2013

Integrated DNA Technologies (United States)
2012

Fera Science (United Kingdom)
2010

Homopurine-homopyrimidine sequences that flank certain actively transcribed genes are hypersensitive to single strand-specific nucleases such as S1. This has raised the possibility an unusual structure exists in these regions might be involved recognition or regulation. Several of sequences, including d(C-T) n ⋅d(A-G) , known undergo a transition plasmids underwound state is nucleases; this occurs under conditions moderately acid p H and negative supercoiling. Chemical probes were used...

10.1126/science.2845572 article EN Science 1988-09-30

RNA interference offers enormous potential to develop therapeutic agents for a variety of diseases. To assess the stability siRNAs under conditions relevant clinical use with particular emphasis on topical delivery considerations, study three different unmodified was performed. The results indicate that neither repeated freeze/thaw cycles, extended incubations (over 1 year at 21 degrees C), nor shorter high temperatures (up 95 C) have any effect siRNA integrity as measured by nondenaturing...

10.1089/oli.2008.0149 article EN Oligonucleotides 2008-10-10

A robust screening assay employing solid phase extraction (SPE) followed by a novel aptamer-based procedure is presented for the rapid detection and semiquantitation of triphenylmethane dye, Malachite Green (MG) its primary metabolite Leucomalachite (LMG) in fish tissue. To authors' knowledge, this first reported use an RNA aptamer development diagnostic chemical residues food. The based found to be highly specific MG; but has negligible affinity LMG metabolite. However, because lipophilic...

10.1021/ac902226v article EN Analytical Chemistry 2010-03-04

Samples of DNA which contain adducts a new psoralen derivative, but no cross-links, have been prepared by irradiating mixtures and the derivative with single, 15-nanosecond pulses laser light. Succeeding introduce cross-links. The ability to rapidly selectively create monoadducts corss-links may allow use psoralens as probes dynamic processes in living cells.

10.1126/science.887929 article EN Science 1977-08-26

Small hairpin RNAs (shRNAs) are widely used in RNAi studies and typically consist of a stem 19–29 base pairs (bp), loop at least 4 nucleotides (nt), dinucleotide overhang the 3′ end. Compared with shRNAs 21–29 bp stems, we have found that 19-bp or shorter stems (sshRNAs) possess some unique structure–activity features depend on whether antisense strand is positioned 5′ to (L- R-type sshRNAs, respectively). L sshRNAs can IC 50 s very low picomolar range, nominal sizes 1 nt were as active...

10.1261/rna.1894510 article EN RNA 2009-12-01

The ability to accurately quantify all the microRNAs (miRNAs) in a sample is important for understanding miRNA biology and development of new biomarkers therapeutic targets. We develop method preparing sequencing libraries, RealSeq®-AC, that involves ligating miRNAs with single adapter circularizing ligation products. When compared other methods, RealSeq®-AC provides greatly reduced bias allows identification largest variety biological samples. This also robust quantification present samples...

10.1186/s13059-018-1488-z article EN cc-by Genome biology 2018-08-07

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTThe chemistry of cyclic vinyl ethers. 6. Total synthesis polyether ionophore antibiotics the calcimycin (A-23187) classRobert K. Boeckman Jr., Andre B. Charette, Theodros Asberom, and Brian H. JohnstonCite this: J. Am. Chem. Soc. 1991, 113, 14, 5337–5353Publication Date (Print):July 1, 1991Publication History Published online1 May 2002Published inissue 1 July...

10.1021/ja00014a029 article EN Journal of the American Chemical Society 1991-07-01

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTA convergent general synthetic protocol for construction of spirocyclic ketal ionophores: an application to the total synthesis (-)-A-23187 (calcimycin)Robert K. Boeckman Jr., Andre B. Charette, Theodros Asberom, and Brian H. JohnstonCite this: J. Am. Chem. Soc. 1987, 109, 24, 7553–7555Publication Date (Print):November 1, 1987Publication History Published online1 May 2002Published inissue 1 November...

10.1021/ja00258a063 article EN Journal of the American Chemical Society 1987-11-01

Treatment and prevention of hepatitis C virus (HCV) infections remain a major challenge for controlling this worldwide health problem; existing therapies are only partially effective no vaccine is currently available. RNA interference offers the potential novel therapeutic approach treating HCV infections. Toward end, we evaluated small hairpin interfering RNAs (shRNAs) targeting conserved internal ribosome entry site (IRES) element genome their ability to control gene expression in human...

10.1016/j.ymthe.2005.04.014 article EN cc-by-nc-nd Molecular Therapy 2005-06-14

Small hairpin RNAs (shRNAs) with 19-base-pair, or shorter, stems (short shRNAs [sshRNAs]) have been found to constitute a class whose mechanism of action appears be distinct from that small interfering (siRNAs) longer shRNAs. These sshRNAs can as active canonical siRNAs Their activity is affected by whether the antisense strand positioned 5′ 3′ loop (L R sshRNAs, respectively). Dicer seems not involved in processing although target gene suppression these hairpins through Ago2-mediated mRNA...

10.1261/rna.1901810 article EN RNA 2009-11-30

Discussion regarding the regulatory status of genome-edited crops has focused on precision editing and doubts feasibility analytical monitoring compliant with existing GMO regulations. Effective detection methods are important, both for enforcement traceability in case biosafety, environmental or socio-economic impacts. Here, we approach analysis question first time laboratory report successful development a quantitative PCR method commercialized crop, canola single base pair edit conferring...

10.3390/foods9091245 article EN cc-by Foods 2020-09-07

Hepatitis C virus (HCV) is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Currently available treatment options are limited efficacy, there an urgent need for development alternative therapies. RNA interference (RNAi) natural mechanism by which small interfering (siRNA) or short hairpin (shRNA) can mediate degradation target molecule in sequence-specific manner. In this study, we screened vitro-transcribed 25-bp shRNAs targeting the internal ribosome entry site...

10.1089/oli.2006.0069 article EN Oligonucleotides 2007-06-01

Recently, we reported for the first time development of pH-triggered nanoparticles functional delivery small interfering RNA (siRNA) to liver treatment hepatitis B virus infections in vivo. Here, report on systematic formulation and biophysical studies three different nanoparticle formulations looking ways improve capabilities our previous system. We demonstrate how pH-triggered, PEGylated siRNA stable with respect aggregation 80% serum can still release payload at pH 5.5 within 30 min. This...

10.1021/bc3004099 article EN Bioconjugate Chemistry 2013-01-10

Small hairpin RNAs (shRNAs) having duplex lengths of 25–29 bp are normally processed by Dicer into short interfering (siRNAs) before incorporation the RNA-induced silencing complex (RISC). However, shRNAs ≤19 [short (sshRNAs)] too for to excise their loops, raising questions about mechanism action. sshRNAs designated as L-type or R-type according whether loop is positioned 3′ 5′ guide sequence, respectively. Using nucleotide modifications that inhibit RNA cleavage, we show R- but not...

10.1093/nar/gks662 article EN cc-by-nc Nucleic Acids Research 2012-07-18

In diabetes-associated chronic wounds, the normal response to hypoxia is impaired and many cellular processes involved in wound healing are hindered. Central hypoxia-inducible factor-1α (HIF-1α), which activates multiple factors that enhance by promoting motility proliferation, new vessel formation, re-epithelialization. Prolyl hydroxylase domain-containing protein 2 (PHD2) regulates HIF-1α activity targeting it for degradation under normoxia. also upregulates microRNA miR-210, turn proteins...

10.1089/ten.tea.2017.0484 article EN Tissue Engineering Part A 2018-04-12

Objective: To evaluate the efficacy of layer-by-layer (LbL) formulated therapeutic RNAs that inhibit PHD2 and microRNA-210 (miR-210), to improve impaired diabetic wound healing. Approach: We employed neuroischemic rabbit model Diabetes was induced in rabbits with alloxan, neuroischemia by ligating central neurovascular bundle each ear. Four 6-mm full-thickness wounds were creating on A technique conformally coat dressings a chemically modified antisense RNA (antimiR) against miR-210 an...

10.1089/wound.2023.0056 article EN Advances in Wound Care 2024-01-06

A significant limitation to the practical application of triplex DNA is its requirement for oligopurine tracts in target sequences. The repertoire triplex-forming sequences can potentially be expanded adjacent blocks purines and pyrimidines by allowing third strand pair with on alternate strands, while maintaining required polarities combining two major classes base triplets, Py · PuPy Pu PuPy. formation this fashion requires no unusual bases or backbone linkages strand. This approach has...

10.1093/nar/20.20.5279 article EN Nucleic Acids Research 1992-01-01

MicroRNAs (miRNAs) are important regulators of gene expression and have great potential as biomarkers, prognostic indicators, therapeutic targets. Determining the patterns these molecules is essential for elucidating their biogenesis, regulation, relation to disease, response therapy. Although PCR-based assays commonly used profiling miRNAs, small size, sequence heterogeneity, (in some cases) end modifications miRNAs constrain performance existing PCR methods. Here we introduce miR-ID, a...

10.1261/rna.2490111 article EN RNA 2010-12-17

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTIntramolecular triple-helix formation at (PunPyn).cntdot.(PunPyn) tracts: recognition of alternate strands via Pu.cntdot.PuPy and Py.cntdot.PuPy base tripletsSumedha D. Jayasena Brian H. JohnstonCite this: Biochemistry 1992, 31, 2, 320–327Publication Date (Print):January 21, 1992Publication History Published online1 May 2002Published inissue 21 January...

10.1021/bi00117a002 article EN Biochemistry 1992-01-21

Methods most commonly used for producing small interfering RNAs (siRNAs) or short hairpin (shRNAs) are chemical synthesis and intracellular expression from engineered vectors. For shRNAs, is very costly construction of vectors laborious. Synthesis by phage RNA polymerases their natural promoters results in a 5´-terminal triphosphate that can trigger an interferon (IFN) response. Moreover, due to the requirement 5´- GPuPuPu sequences transcription initiation, shRNA transcripts may have extra...

10.1089/oli.2006.16.353 article EN Oligonucleotides 2006-12-01
Coming Soon ...